SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,695,000 | -26.1% | 58,078 | -22.1% | 0.00% | -70.0% |
| Q2 2021 | $2,295,000 | -26.1% | 74,552 | -37.1% | 0.01% | -28.6% |
| Q1 2021 | $3,105,000 | +22.1% | 118,609 | +17.3% | 0.01% | 0.0% |
| Q4 2020 | $2,543,000 | -27.0% | 101,109 | -39.5% | 0.01% | -36.4% |
| Q3 2020 | $3,483,000 | -65.2% | 167,137 | -60.3% | 0.02% | -68.6% |
| Q2 2020 | $10,001,000 | +97.7% | 421,100 | +49.8% | 0.07% | +37.3% |
| Q1 2020 | $5,058,000 | -33.3% | 281,169 | -12.0% | 0.05% | -1.9% |
| Q4 2019 | $7,582,000 | -56.6% | 319,663 | -49.7% | 0.05% | -62.0% |
| Q3 2019 | $17,470,000 | -5.5% | 635,748 | +13.8% | 0.14% | -9.9% |
| Q2 2019 | $18,488,000 | -58.3% | 558,703 | -55.8% | 0.15% | -27.3% |
| Q1 2019 | $44,342,000 | +214.8% | 1,265,460 | +198.5% | 0.21% | +45.1% |
| Q4 2018 | $14,085,000 | +2661.8% | 423,964 | +4089.4% | 0.14% | +7100.0% |
| Q3 2018 | $510,000 | +5.4% | 10,120 | -68.1% | 0.00% | -60.0% |
| Q1 2016 | $484,000 | -79.4% | 31,747 | -81.8% | 0.01% | -77.3% |
| Q4 2015 | $2,345,000 | – | 174,513 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |